Elizabeth Turner has spent her career working across sales leadership, marketing and market access functions at biopharmaceutical companies of varying therapeutic focus and development stages. Liz currently serves as Vice President, Global Market Access at Mirum. Prior to Mirum, she served in similar roles at Galera Therapeutics and Arena Pharmaceuticals. Before her transition to Market Access, Liz served in both marketing and sales roles of increasing leadership responsibility for 10 years at Amgen and five years at Pfizer. Liz holds an MBA from the University of Central Florida and a BA in mass communications from the University of South Florida.

Dagmar Albers is a transformation strategist and award‑winning consultant with more than 25 years’ experience in Pharma and FMCG, supporting organisations unlock clarity, confidence and capability in a fast‑changing world. She specialises in translating customer and employee insights into smarter strategies, stronger positioning and sustainable business impact, combining data, adaptive roadmapping and bold creative thinking to turn complexity into clarity.

As Co‑Founder of Innovationin, a 2025 and 2026 finalist for New Business of the Year, Dagmar partners with organisations ready for a workplace revolution to thrive in a world shaped by AI, hybrid work and shifting career paths. Her work blends behavioural science, leadership development, equity and customer insight to strengthen the people side of AI transformation, ensuring change is measurable, meaningful and lasting.
Previously, Dagmar designed and delivered Pfizer UK’s award‑winning Gender and Ethnicity Pay Gap strategy and is co‑author of Innovationin'sThe Visibility Advantage (2025), a practical toolkit for building confidence, influence and career agility.

Dagmar serves as Vice President, EMEA for the Healthcare Businesswomen’s Association (HBA), shaping the healthcare ecosystem to accelerate equity and develop leaders for life. She is a recipient of the HBA ACE Award, recognised for leading Pfizer UK’s breakthrough strategy that halved the organisation’s gender pay gap in just four years — from 15.9% to 6.6%.

Marie-Caroline Chauvet is a Partner at Insigniam with over 18 years of experience in leadership and strategy development. Before her successful consulting career, Marie-Caroline spent years at L'Oréal, where she served as the Vice President of Finance for their Professional Products Division in France. She is an expert in navigating multicultural teams and driving measurable ROI through innovation. 

Jounal Shaikh is a Executive Supply Chain Leader at Bristol Myers Squibb and has dedicated over two decades to ensuring global supply chains deliver for the people who need them most: the patients. With a career spanning giants like Roche, Johnson & Johnson and Novartis, Jounal is an expert in navigating disruption and building agile, data-driven operations along with a wealth of experience in M&A integrations and inventory optimization, all viewed through the lens of patient-centric outcomes.

As co-founder of DKI Health, a strategy consulting firm, Deepa leads a global team of healthcare professionals who share a vision to “create a world where good health is possible, accessible, and equitable.”

With two decades of industry experience, Deepa’s expertise lies in leadership development, commercial strategy, market access, health policy, and patient advocacy. Her therapeutic area expertise ranges from oncology and immunology to infectious and rare diseases. She has published on several topics including biologics and biosimilars, antimicrobial resistance, COVID, patient advocacy, and health equity.

Previously, Deepa worked IQVIA (IMS, Quintiles) and Syneos Health (Campbell Alliance). She holds masters and undergraduate degrees from the University of New Hampshire and University of Idaho, respectively.

As a global citizen seeking to improve access and equity in health, Deepa is passionate about engaging with others on ways we can make an impact together.

Susan Childs is highly recognized within the Healthcare, pharmaceutical and biotech industry where she has been an executive with top companies. Currently she is Founder and Principal Managing Partner for LCA Enterprise & Consulting, LLC focused inclusive thought leadership, racial bias awareness, workforce inclusion, cultural diversity and strategic business and people optimizations. She also consults as ana venture capital firm Fractional CHRO.

Susan is an active member of HBA and has become a notable speaker, facilitator and moderator for many programs and events like the Annual Conference panelist, moderator and fireside chat host. She also consults with the HBA Gender Equity Think Tank and the Global Ambassador Program. She serves as a guest faculty speaker for entrepreneur cohorts at the Texas Medical Center for Cancer Research Innovations in Houston, TX where her curriculum connects business excellence to people, culture, ethics, engagement and innovation.